Products

Antibodies

Primary Antibodies

RALA

Human

Mouse

Rat

Monkey

Dog

Human (Predicted: Mouse

Canine

Bovine

Chicken

Rat)

Bovine)

Hamster

Pig

Pig)

Human (Expected from sequence similarity: Mouse

Primate

Zebrafish

Cow)

Drosophila

Xenopus)

Mouse (Predicted: Rat

Rabbit

Rabbit)

Xenopus

Canis

Chimpanzee

Dog)

Gerbil

Human (Predicted: Mouse)

Human (Predicted: Rhesus Monkey)

Mouse (Predicted: Pig

Rat (Expected from sequence similarity: Dog

X. tropicalis

C. elegans (Does not react with: Human

C. elegans)

Chicken)

Cow

Drosophila)

Equine

Guinea Pig

Horse

Human (Does not react with: Mouse)

Human (Expected from sequence similarity: Dog

Human (Expected from sequence similarity: Dog)

Human (Predicted: Bat

Human (Predicted: Dog

Human (Predicted: Hamster

Human (Predicted: Monkey)

Mammalian

Mouse (Expected from sequence similarity: Human)

Mouse (Predicted: Chicken

Mouse (Predicted: Dog)

Mouse (Predicted: Rhesus Monkey)

Porcine

Sheep

Tobacco hornworm

X. tropicalis)

Yeast (Does not react with: Xenopus)

WB

Rabbit

Unconjugated

IgG

Polyclonal

Druggable Genome

Metabolic pathways

Pathways in cancer

MAPK signaling pathway

Wnt signaling pathway

Alanine

Basal cell carcinoma

Butanoate metabolism

Calcium signaling pathway

Cysteine and methionine metabolism

ErbB signaling pathway

Fc epsilon RI signaling pathway

Fc gamma R-mediated phagocytosis

Focal adhesion

Gap junction

Glioma

GnRH signaling pathway

Hedgehog signaling pathway

Leukocyte transendothelial migration

Long-term depression

Long-term potentiation

Melanogenesis

Natural killer cell mediated cytotoxicity

Non-small cell lung cancer

O-Glycan biosynthesis

Pancreatic cancer

Pathogenic Escherichia coli infection

Phosphatidylinositol signaling system

Regulation of actin cytoskeleton

Taurine and hypotaurine metabolism

Tight junction

Type I diabetes mellitus

VEGF signaling pathway

Vascular smooth muscle contraction

Vibrio cholerae infection

aspartate and glutamate metabolism

beta-Alanine metabolism

2